These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20515283)

  • 1. Biomarkers for rheumatoid arthritis: making it personal.
    Lindstrom TM; Robinson WH
    Scand J Clin Lab Invest Suppl; 2010; 242():79-84. PubMed ID: 20515283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievements and challenges of proteomics in the study of rheumatoid arthritis.
    Ruiz-Romero C; Blanco FJ
    Curr Top Med Chem; 2013; 13(6):732-42. PubMed ID: 23574522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.
    Lourido L; Blanco FJ; Ruiz-Romero C
    Expert Rev Proteomics; 2017 May; 14(5):431-444. PubMed ID: 28425787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
    Castro-Santos P; Laborde CM; Díaz-Peña R
    Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine and management of rheumatoid arthritis.
    Aletaha D
    J Autoimmun; 2020 Jun; 110():102405. PubMed ID: 32276742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic markers of early rheumatoid arthritis.
    Staikova ND; Kuzmanova SI; Solakov PT
    Folia Med (Plovdiv); 2003; 45(3):35-42. PubMed ID: 15366664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
    Kudo-Tanaka E; Ohshima S; Ishii M; Mima T; Matsushita M; Azuma N; Harada Y; Katada Y; Ikeue H; Umeshita-Sasai M; Miyatake K; Saeki Y
    Clin Rheumatol; 2007 Oct; 26(10):1627-33. PubMed ID: 17286215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.
    Martinez-Prat L; Palterer B; Vitiello G; Parronchi P; Robinson WH; Mahler M
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1073-1087. PubMed ID: 31524005
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
    de Brito Rocha S; Baldo DC; Andrade LEC
    Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA; Esmail MA; Ali RM; Mohafez OM
    Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
    Wu CY; Yang HY; Luo SF; Lai JH
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest.
    Cordero OJ; Varela-Calviño R; López-González T; Grujic M; Juranic Z; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; de la Iglesia BA; Pego-Reigosa JM
    Clin Biochem; 2017 Nov; 50(16-17):903-910. PubMed ID: 28599787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic: new advances in the diagnosis of rheumatoid arthritis.
    Tampoia M; Brescia V; Fontana A; Maggiolini P; Zucano A; Pansini N
    Clin Chim Acta; 2005 Jul; 357(2):219-25. PubMed ID: 15896730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable and cost-effective serodiagnosis of rheumatoid arthritis.
    Meyer PW; Ally MM; Anderson R
    Rheumatol Int; 2016 Jun; 36(6):751-8. PubMed ID: 26856871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis.
    De Winter LM; Hansen WL; van Steenbergen HW; Geusens P; Lenaerts J; Somers K; Stinissen P; van der Helm-van Mil AH; Somers V
    Rheumatology (Oxford); 2016 Aug; 55(8):1431-6. PubMed ID: 27094600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential roles for novel biomarkers in rheumatoid arthritis assessment.
    Mease PJ
    Clin Exp Rheumatol; 2011; 29(3):567-74. PubMed ID: 21640052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics Analysis for Verification of Rheumatoid Arthritis Biomarker Candidates Using Multiple Reaction Monitoring.
    Lee J; Mun S; Kim D; Lee YR; Sheen DH; Ihm C; Lee SH; Kang HG
    Proteomics Clin Appl; 2019 May; 13(3):e1800011. PubMed ID: 30230224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted antibody therapy and relevant novel biomarkers for precision medicine for rheumatoid arthritis.
    Kaneko Y; Takeuchi T
    Int Immunol; 2017 Dec; 29(11):511-517. PubMed ID: 29069431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.
    Márquez A; Martín J; Carmona FD
    Expert Rev Mol Diagn; 2016 Jun; 16(6):663-75. PubMed ID: 27043155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
    Maksymowych WP; Boire G; van Schaardenburg D; Wichuk S; Turk S; Boers M; Siminovitch KA; Bykerk V; Keystone E; Tak PP; van Kuijk AW; Landewé R; van der Heijde D; Murphy M; Marotta A
    J Rheumatol; 2015 Sep; 42(9):1587-94. PubMed ID: 26178283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.